1. Home
  2. MNDO vs LSTA Comparison

MNDO vs LSTA Comparison

Compare MNDO & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND C.T.I. Ltd.

MNDO

MIND C.T.I. Ltd.

HOLD

Current Price

$1.23

Market Cap

24.4M

Sector

Technology

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.97

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDO
LSTA
Founded
1995
1980
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Misc Health and Biotechnology Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.4M
20.9M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
MNDO
LSTA
Price
$1.23
$1.97
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
52.3K
33.7K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
17.89%
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$19,770,000.00
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$1.81
52 Week High
$2.13
$4.20

Technical Indicators

Market Signals
Indicator
MNDO
LSTA
Relative Strength Index (RSI) 63.42 40.21
Support Level $1.18 $1.85
Resistance Level $1.22 $2.09
Average True Range (ATR) 0.03 0.16
MACD 0.00 0.01
Stochastic Oscillator 90.00 34.41

Price Performance

Historical Comparison
MNDO
LSTA

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: